Unified Data Experience from Medidata Paves Way for New Industry Standard Across Leading Biopharma Companies and Contract Research Organizations Clinical Data Studio has supported 465 global studies since its launch in 2024, reducing data review cycles by up to 80% and accelerating patient profile reviews by 50% NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that , its AI-powered data management solution and an integral part of the , has seen a rise in adoption with m...
Temenos named best-selling core banking provider for 20th consecutive year by IBS Intelligence Temenos ranked #1 in 13 categories in the IBSi Sales League table, including core, digital, payments and wealth GRAND-LANCY, Switzerland, June 13, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader in banking technology, today announced it has been recognized as the #1 best-selling software provider in 13 categories in the . Temenos ranked #1 for core banking for the 20th consecutive year, while also topping the table for categories covering digital, payments, wealth and Islamic b...
A director at Temenos AG sold 622 shares at 60.863CHF and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...
NOTICE TO DISREGARD -- Medidata Solutions, Inc. NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- We are advised by Medidata Solutions, Inc. that journalists and other readers should disregard the news release, "Medidata Sees Strong Momentum with Key Customer Wins, Advances in CNS and Digital Therapeutics, and Expanded Market Leadership" issued June 3, 2025 at 8:00am ET, over GlobeNewswire.
Medidata Sees Strong Momentum with Key Customer Wins, Advances in CNS and Digital Therapeutics, and Expanded Market Leadership Continued focus on patients, customers, and innovation helping to drive new advances in clinical research for life science companies NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand, has seen significant momentum and reaffirmed its vision to progress the life sciences industry forward, securing new enterprise agreements with several large customers, a strengthened industry partnership in central nervous system (CNS), a strengthened presenc...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.